Inito key facts
as of Oct 2026- Developer of an at-home fertility monitoring device designed to track hormone levels and confirm ovulation for deeper reproductive health insights.
- Inito is valued at approximately $3.6M as of Oct 2026 (last reported valuation).
- It has raised $37.7M; the latest was Later Stage VC ($29.0M) in Dec 2025.
- Notable investors include Y Combinator, Astir Ventures, 2468 Ventures, Fireside Ventures, Kishore Ganji — 21 tracked in total.
- Status: Privately Held (backing).
Inito's last reported valuation, Dec 2017. Nothing priced has surfaced since.
- ·The complete investor list: 21 names
- ·Watch Inito: the Monday email on marks, rounds and moves
Inito funding rounds
No funding rounds for Inito are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Inito
21+Membership and data by Private Market View
Inito valuation
Inito's last reported valuation was $3.6 million in Dec 2017. No priced round, secondary trade or fund mark has surfaced since.
Inito investors
21 investors are on record for Inito, including Y Combinator, Astir Ventures, 2468 Ventures and Fireside Ventures. By type, the record holds 6 venture capital firms and 1 angel investor.
About Inito
Developer of an at-home fertility monitoring device designed to track hormone levels and confirm ovulation for deeper reproductive health insights. The company offers a device with multi-hormone tracking, personalized fertility analysis, and an extensive global test database, enabling individuals seeking fertility guidance and broader hormonal health understanding to make informed decisions about their reproductive well-being.
- Sector
- Healthcare
- HQ
- Bengaluru, India
- Founded
- 2012
- Employees
- 200
- Website
- inito.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.